Company news

Bio-Techne Corp news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics

June 10, 2025

Bio-Techne to Present at Investor Conferences

May 28, 2025

ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA)

May 13, 2025

Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025

May 11, 2025

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing

May 7, 2025

Bio-Techne to Present at the BofA Securities 2025 Health Care Conference

May 7, 2025

Bio-Techne releases third quarter fiscal 2025 results

May 6, 2025

Bio-Techne declares dividend and new share repurchase program

May 6, 2025

ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc.

May 6, 2025

ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy

April 29, 2025

Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection

April 23, 2025

Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting

April 22, 2025

Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results

April 14, 2025

Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument

April 1, 2025

Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany

March 25, 2025

Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting

March 23, 2025

Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System

March 9, 2025

Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes

March 2, 2025

Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology

February 19, 2025

Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System

February 17, 2025

Bio-Techne Releases Second Quarter Fiscal 2025 Results

February 4, 2025

Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors

February 3, 2025

Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results

January 20, 2025

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine

January 9, 2025

Bio-Techne to present at phacilitate advanced therapies week 2025

January 7, 2025

Bio-Techne successful on second claim of reverse engineering by Miltenyi biotec

January 6, 2025

Bio-Techne to present at the 43rd annual j.p. morgan healthcare conference

December 19, 2024

Bio-Techne announces biotherapeutic characterization strategic co-marketing and co-promotion agreement

December 18, 2024

Bio-Techne announces new distribution agreement with MedSanTek to expand access to portfolio across Turkey

December 11, 2024

Bio-Techne launches ESR1 mutation monitoring assay

December 9, 2024

Bio-Techne to present at the citi 2024 global healthcare conference

November 26, 2024

Bio-Techne announces new distribution agreement with Leader Life Sciences

November 19, 2024

BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH

November 17, 2024

Bio-Techne to highlight novel solutions for cancer and carrier screening at AMP 2024 annual meeting & expo

November 13, 2024

Bio-Techne announces IVDR certified hematology controls and Calibrators

November 10, 2024

Bio-Techne to present at investor conferences

November 7, 2024

Bio-Techne to present at the society for immunotherapy of cancer (sitc) 39th annual meeting

November 5, 2024

Lunaphore COMET™ platform paves the way for spatial biology adoption in clinical research

November 4, 2024

Bio-Techne releases first quarter fiscal 2025 results

October 29, 2024

Bio-Techne to host conference call on October 30, 2024, to announce first quarter fiscal 2025 financial results

October 9, 2024

Bio-Techne to present at Neuroscience 2024-the society for Neuroscience (SfN) annual meeting

September 23, 2024

Bio-Techne issues 2024 corporate sustainability report

September 17, 2024

ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics

September 16, 2024

ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex® Manufacture of CAR-T and TCR Therapies

September 15, 2024

Bio-Techne to present at investor healthcare conferences

August 25, 2024

Bio-Techne releases fourth quarter fiscal 2024 results

August 6, 2024

Bio-Techne announces next-generation high throughput Simple Western System

July 30, 2024

Bio-Techne announces strategic investment in Spear Bio

July 28, 2024

Bio-Techne to host conference call on August 7, 2024, to announce fourth quarter and fiscal 2024 financial results

July 14, 2024

Bio-Techne to present at upcoming investor conferences

May 30, 2024

← Newer news releases · Older news releases →

Calls

The 5 newest of 27 calls. Every call is listed under its year.

Decks

The 5 newest of 16 decks. Every deck is listed under its year.